PortfoliosLab logoPortfoliosLab logo
SNDK vs. MEDP
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SNDK vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sandisk Corp (SNDK) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SNDK vs. MEDP - Yearly Performance Comparison


2026 (YTD)2025
SNDK
Sandisk Corp
191.82%388.44%
MEDP
Medpace Holdings, Inc.
-12.85%63.10%

Fundamentals

Market Cap

SNDK:

$108.07B

MEDP:

$14.18B

EPS

SNDK:

-$6.94

MEDP:

$15.23

PS Ratio

SNDK:

11.64

MEDP:

5.73

PB Ratio

SNDK:

10.58

MEDP:

30.88

Total Revenue (TTM)

SNDK:

$8.93B

MEDP:

$2.53B

Gross Profit (TTM)

SNDK:

$3.11B

MEDP:

$760.62M

EBITDA (TTM)

SNDK:

-$589.00M

MEDP:

$541.22M

Returns By Period

In the year-to-date period, SNDK achieves a 191.82% return, which is significantly higher than MEDP's -12.85% return.


SNDK

1D
9.03%
1M
11.90%
YTD
191.82%
6M
471.94%
1Y
1,339.89%
3Y*
5Y*
10Y*

MEDP

1D
1.93%
1M
7.00%
YTD
-12.85%
6M
-10.01%
1Y
64.40%
3Y*
37.56%
5Y*
23.60%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNDK vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNDK
SNDK Risk / Return Rank: 9999
Overall Rank
SNDK Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
SNDK Sortino Ratio Rank: 9999
Sortino Ratio Rank
SNDK Omega Ratio Rank: 9898
Omega Ratio Rank
SNDK Calmar Ratio Rank: 100100
Calmar Ratio Rank
SNDK Martin Ratio Rank: 100100
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7878
Overall Rank
MEDP Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 8383
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8484
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7575
Calmar Ratio Rank
MEDP Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNDK vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sandisk Corp (SNDK) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SNDKMEDPDifference

Sharpe ratio

Return per unit of total volatility

13.55

0.96

+12.59

Sortino ratio

Return per unit of downside risk

5.32

2.33

+2.99

Omega ratio

Gain probability vs. loss probability

1.77

1.32

+0.45

Calmar ratio

Return relative to maximum drawdown

35.26

1.84

+33.42

Martin ratio

Return relative to average drawdown

88.02

5.41

+82.61

SNDK vs. MEDP - Sharpe Ratio Comparison

The current SNDK Sharpe Ratio is 13.55, which is higher than the MEDP Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of SNDK and MEDP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SNDKMEDPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

13.55

0.96

+12.59

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

10.44

0.70

+9.74

Correlation

The correlation between SNDK and MEDP is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SNDK vs. MEDP - Dividend Comparison

Neither SNDK nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SNDK vs. MEDP - Drawdown Comparison

The maximum SNDK drawdown since its inception was -47.50%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for SNDK and MEDP.


Loading graphics...

Drawdown Indicators


SNDKMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-47.50%

-42.87%

-4.63%

Max Drawdown (1Y)

Largest decline over 1 year

-37.86%

-32.96%

-4.90%

Max Drawdown (5Y)

Largest decline over 5 years

-42.87%

Current Drawdown

Current decline from peak

-10.28%

-21.13%

+10.85%

Average Drawdown

Average peak-to-trough decline

-15.40%

-12.64%

-2.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.39%

11.21%

+4.18%

Volatility

SNDK vs. MEDP - Volatility Comparison

Sandisk Corp (SNDK) has a higher volatility of 30.47% compared to Medpace Holdings, Inc. (MEDP) at 11.03%. This indicates that SNDK's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SNDKMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.47%

11.03%

+19.44%

Volatility (6M)

Calculated over the trailing 6-month period

80.77%

29.61%

+51.16%

Volatility (1Y)

Calculated over the trailing 1-year period

100.02%

67.76%

+32.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

97.99%

50.91%

+47.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

97.99%

49.57%

+48.42%

Financials

SNDK vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Sandisk Corp and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B2.50B3.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
3.03B
708.45M
(SNDK) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

SNDK vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Sandisk Corp and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-10.0%0.0%10.0%20.0%30.0%40.0%50.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
50.9%
29.0%
Portfolio components
SNDK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Sandisk Corp reported a gross profit of 1.54B and revenue of 3.03B. Therefore, the gross margin over that period was 50.9%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a gross profit of 205.32M and revenue of 708.45M. Therefore, the gross margin over that period was 29.0%.

SNDK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Sandisk Corp reported an operating income of 1.07B and revenue of 3.03B, resulting in an operating margin of 35.2%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported an operating income of 153.27M and revenue of 708.45M, resulting in an operating margin of 21.6%.

SNDK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Sandisk Corp reported a net income of 803.00M and revenue of 3.03B, resulting in a net margin of 26.6%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a net income of 135.13M and revenue of 708.45M, resulting in a net margin of 19.1%.